TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹101 Cr | ₹-142 Cr | ₹-300 Cr | ₹-422 Cr | ₹-433 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹101 Cr |
Mar2023 | ₹-142 Cr |
Mar2022 | ₹-300 Cr |
Mar2021 | ₹-422 Cr |
Mar2020 | ₹-433 Cr |
How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹101 Cr | Positive | |
Mar2023 | ₹-142 Cr | Negative | |
Mar2022 | ₹-300 Cr | Negative | |
Mar2021 | ₹-422 Cr | Negative | |
Mar2020 | ₹-433 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹105,834.6 Cr | -4.8% | 1.9% | 20.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,900.0 Cr | -1.3% | 4.7% | 3.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,474.0 Cr | 1.9% | 1.5% | 41.9% | Stock Analytics | |
CIPLA | ₹118,166.0 Cr | 3.4% | 0.1% | -3.1% | Stock Analytics | |
MANKIND PHARMA | ₹97,009.6 Cr | -4% | 4% | -1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,553.6 Cr | -0.1% | -1% | -11.3% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -4.8% |
1.9% |
20.3% |
SENSEX | -1.5% |
1.1% |
1.2% |
You may also like the below Video Courses